Hsu Eric C.'s Insider Trades & SAST Disclosures
Hsu Eric C.'s most recent trade in InMed Pharmaceuticals Inc was a trade of 2,750 Employee Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Dec. 20, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Hsu Eric C..To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| InMed Pharmaceuticals Inc | Hsu Eric C. | Sr. VP, Pre-Clinical Res/Dev | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Dec 2024 | 2,750 | 5,350 | - | - | Employee Stock Option (Right to Buy) | |
| InMed Pharmaceuticals Inc | Eric C. Hsu | Sr. VP, Pre-Clinical Res/Dev | 27 May 2024 | 545 | 52,000 | - | - | Employee Stock Option (Expiration) | ||
| InMed Pharmaceuticals Inc | Eric C. Hsu | Sr. VP, Pre-Clinical Res/Dev | 04 Mar 2024 | 309 | 52,545 | - | - | Employee Stock Option (Expiration) | ||
| InMed Pharmaceuticals Inc | Hsu C. Eric | Sr. VP, Pre-Clinical Res/Dev | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2023 | 45,000 | 52,854 | - | - | Employee Stock Option (Right to Buy) | |
| InMed Pharmaceuticals Inc | Eric C. Hsu | Sr. VP, Pre-Clinical Res/Dev | 31 Aug 2023 | 327 | 7,854 | - | - | Employee Stock Option (Expiration) | ||
| InMed Pharmaceuticals Inc | Eric C. Hsu | Sr. VP, Pre-Clinical Res/Dev | 16 May 2023 | 152 | 8,181 | - | - | Employee Stock Option (Expiration) | ||
| InMed Pharmaceuticals Inc | Eric C. Hsu | Sr. VP, Pre-Clinical Res/Dev | 08 Mar 2023 | 545 | 8,333 | - | - | Employee Stock Option (Expiration) | ||
| InMed Pharmaceuticals Inc | Eric C. Hsu | Sr. VP, Pre-Clinical Res/Dev | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Dec 2022 | 4,200 | 8,878 | - | - | Employee Stock Option (Right to Buy) | |
| InMed Pharmaceuticals Inc | Eric C. Hsu | Sr. VP, Pre-Clinical Res/Dev | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Nov 2022 | 4,200 | 8,878 | - | - | Employee Stock Option (Right to Buy) | |
| InMed Pharmaceuticals Inc | Eric C. Hsu | Sr. VP, Pre-Clinical Res/Dev | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Oct 2021 | 35,000 | 116,969 | - | - | Employee Stock Option (Right to Buy) | |
| InMed Pharmaceuticals Inc | Eric C. Hsu | Sr. VP, Pre-Clinical Res/Dev | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Dec 2020 | 35,000 | 35,000 | - | - | Employee Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges